• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例纯合子家族性高胆固醇血症合并局灶节段性肾小球硬化症。

A case of homozygous familial hypercholesterolemia with focal segmental glomerulosclerosis.

作者信息

Elmaci Ahmet Midhat, Peru Harun, Akin Fatih, Akcoren Zuhal, Caglar Melda, Ozel Ahmet

机构信息

Department of Pediatric Nephrology, School of Meram Medicine, University of Selcuk, 42080 Konya, Turkey.

出版信息

Pediatr Nephrol. 2007 Oct;22(10):1803-5. doi: 10.1007/s00467-007-0534-y. Epub 2007 Jul 17.

DOI:10.1007/s00467-007-0534-y
PMID:17636341
Abstract

Familial hypercholesterolemia (FH) is a common autosomal dominant inherited disorder characterized by increased levels of circulating plasma low-density lipoprotein cholesterol (LDL-C), tendon xanthomas, and premature atherosclerotic cardiovascular disease. Homozygous FH occurs in only one in a million people. Focal segmental glomerulosclerosis (FSGS) is clinically characterized by proteinuria, which is marked in the majority of cases and accompanied by nephrotic syndrome, high incidence of hypertension, and progression to renal failure. To our knowledge, we herein report for the first time a case of homozygous FH associated with FSGS. A seven-and-a-half-year-old boy was referred to our hospital due to cutaneous xanthomata and growth retardation. He had multiple nodular yellowish cutaneous xanthomatous lesions each 1 cm in size over his knees and sacral region. Laboratory data included cholesterol level of 1,050 mg/dl, low density lipoprotein cholesterol (LDL-C) 951 mg/dl, high-density lipoprotein cholesterol (HDL-C) 29 mg/dl, triglycerides 168 mg/dl, total protein 6.3 g/dl, and albumin 3.2 g/dl. Urinary protein excretion was 78 mg/m(2) per hour. A percutaneous renal biopsy was performed, and histological findings showed FSGS. Treatment with cholestyramine and atorvastatin was unsuccessful in terms of lowering lipids, and he was placed on weekly sessions of plasmapheresis. Total cholesterol was reduced from 1,050 mg/dl to 223 mg/dl, LDL-C from 951 mg/dl to 171 mg/dl, and urinary protein excretion from 78 mg/m(2) per hour to 42 mg/m(2) per hour after eight sessions of plasmapheresis. It is our belief that plasmapheresis is a treatment of choice in patients with FSGS associated with FH.

摘要

家族性高胆固醇血症(FH)是一种常见的常染色体显性遗传性疾病,其特征为循环血浆低密度脂蛋白胆固醇(LDL-C)水平升高、肌腱黄色瘤和早发性动脉粥样硬化性心血管疾病。纯合子FH在每百万人中仅出现一例。局灶节段性肾小球硬化症(FSGS)的临床特征为蛋白尿,大多数病例中蛋白尿明显,并伴有肾病综合征、高血压高发病率以及进展为肾衰竭。据我们所知,我们在此首次报告一例与FSGS相关的纯合子FH病例。一名七岁半男孩因皮肤黄色瘤和生长发育迟缓被转诊至我院。他的膝盖和骶骨区域有多个大小为1厘米的结节状黄色皮肤黄色瘤病变。实验室数据包括胆固醇水平1050毫克/分升、低密度脂蛋白胆固醇(LDL-C)951毫克/分升、高密度脂蛋白胆固醇(HDL-C)29毫克/分升、甘油三酯168毫克/分升、总蛋白6.3克/分升和白蛋白3.2克/分升。尿蛋白排泄量为每小时78毫克/平方米。进行了经皮肾活检,组织学检查结果显示为FSGS。使用考来烯胺和阿托伐他汀治疗在降低血脂方面未取得成功,于是对他进行每周一次的血浆置换治疗。经过八次血浆置换后,总胆固醇从1050毫克/分升降至223毫克/分升,LDL-C从951毫克/分升降至171毫克/分升,尿蛋白排泄量从每小时78毫克/平方米降至42毫克/平方米。我们认为血浆置换是治疗与FH相关的FSGS患者的首选治疗方法。

相似文献

1
A case of homozygous familial hypercholesterolemia with focal segmental glomerulosclerosis.一例纯合子家族性高胆固醇血症合并局灶节段性肾小球硬化症。
Pediatr Nephrol. 2007 Oct;22(10):1803-5. doi: 10.1007/s00467-007-0534-y. Epub 2007 Jul 17.
2
[Three-year-old boy--a homozygote for familiar hypercholesterolemia].三岁男孩——家族性高胆固醇血症纯合子
Lijec Vjesn. 2007 May;129(5):130-3.
3
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.丹麦家族性高胆固醇血症的分子遗传基础与诊断
Dan Med Bull. 2002 Nov;49(4):318-45.
4
Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis.低密度脂蛋白分离术治疗局灶节段性肾小球硬化的长期疗效
Pediatr Nephrol. 2007 Jun;22(6):889-92. doi: 10.1007/s00467-006-0426-6. Epub 2007 Feb 3.
5
Reduced apolipoprotein E-rich high-density lipoprotein level at birth is restored to the normal range in patients with familial hypercholesterolemia in the first year of life.出生时富含载脂蛋白E的高密度脂蛋白水平降低,在家族性高胆固醇血症患者出生后的第一年恢复到正常范围。
J Clin Endocrinol Metab. 2008 Mar;93(3):779-83. doi: 10.1210/jc.2007-1621. Epub 2008 Jan 8.
6
Emerging LDL therapies: Mipomersen-antisense oligonucleotide therapy in the management of hypercholesterolemia.新兴的 LDL 治疗药物:米泊美生——反义寡核苷酸疗法在高胆固醇血症治疗中的应用。
J Clin Lipidol. 2013 May-Jun;7(3 Suppl):S6-10. doi: 10.1016/j.jacl.2013.02.004. Epub 2013 Mar 27.
7
Autosomal recessive hypercholesterolemia in a kindred of Syrian ancestry.叙利亚血统家族中的常染色体隐性高胆固醇血症。
J Clin Lipidol. 2020 Jul-Aug;14(4):419-424. doi: 10.1016/j.jacl.2020.06.002. Epub 2020 Jun 8.
8
Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia.纯合子家族性高胆固醇血症儿科患者的低密度脂蛋白分离术
Ther Apher Dial. 2009 Apr;13(2):121-8. doi: 10.1111/j.1744-9987.2009.00666.x.
9
[Significance of serum cholesterol and fibrinogen in evaluating the risk of glomerulosclerosis in children with nephrotic syndrome].[血清胆固醇和纤维蛋白原在评估肾病综合征患儿肾小球硬化风险中的意义]
Zhongguo Dang Dai Er Ke Za Zhi. 2014 Apr;16(4):356-60.
10
[Lipoprotein(a) is associated to atherosclerosis in primary hypercholesterolemia].[脂蛋白(a)与原发性高胆固醇血症中的动脉粥样硬化相关]
Clin Investig Arterioscler. 2014 Jul-Aug;26(4):176-83. doi: 10.1016/j.arteri.2014.01.001. Epub 2014 Feb 25.

引用本文的文献

1
Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis.血浆及经血浆处理的足细胞的蛋白质组学:在局灶节段性肾小球硬化中的应用
Int J Mol Sci. 2023 Jul 28;24(15):12124. doi: 10.3390/ijms241512124.
2
Autosomal Recessive Hypercholesterolemia Caused by a Novel Variant and Membranous Nephropathy in a Chinese Girl: A Case Report.一名中国女孩因新型变异导致的常染色体隐性高胆固醇血症及膜性肾病:病例报告
Front Cardiovasc Med. 2022 Feb 4;9:811317. doi: 10.3389/fcvm.2022.811317. eCollection 2022.
3
Alteration of the Fatty Acid Metabolism in the Rat Kidney Caused by the Injection of Serum from Patients with Collapsing Glomerulopathy.

本文引用的文献

1
Difference in the risk factors for coronary, renal and other peripheral arteriosclerosis in heterozygous familial hypercholesterolemia.杂合子家族性高胆固醇血症患者冠状动脉、肾动脉及其他外周动脉硬化危险因素的差异。
Circ J. 2004 Jul;68(7):623-7. doi: 10.1253/circj.68.623.
2
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.美国国家胆固醇教育计划(NCEP)成人高血胆固醇检测、评估与治疗专家小组第三次报告(成人治疗小组第三次报告)最终报告。
Circulation. 2002 Dec 17;106(25):3143-421.
3
Hypercholesterolemia and glomerular diseases in urinary screening of school children.
注射塌陷型肾小球病患者血清导致大鼠肾脏脂肪酸代谢的改变
Biomedicines. 2020 Sep 29;8(10):388. doi: 10.3390/biomedicines8100388.
4
The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction.肾脂毒性与线粒体功能障碍的恶性循环
Front Physiol. 2020 Jul 7;11:732. doi: 10.3389/fphys.2020.00732. eCollection 2020.
5
Lipid biology of the podocyte--new perspectives offer new opportunities.足细胞的脂质生物学——新视角带来新机遇。
Nat Rev Nephrol. 2014 Jul;10(7):379-88. doi: 10.1038/nrneph.2014.87. Epub 2014 May 27.
学龄儿童尿液筛查中的高胆固醇血症和肾小球疾病
Pediatr Nephrol. 1999 Feb;13(2):125-8. doi: 10.1007/s004670050577.
4
Lipids and the kidney.脂质与肾脏
Kidney Int. 1994 Sep;46(3):910-20. doi: 10.1038/ki.1994.349.
5
LDL-apheresis; potential procedure for prevention and regression of atheromatous vascular lesion.低密度脂蛋白清除术;预防和消退动脉粥样硬化性血管病变的潜在方法。
Jpn Circ J. 1987 Sep;51(9):1116-22. doi: 10.1253/jcj.51.1116.
6
Portacaval shunt and liver transplantation in treatment of familial hypercholesterolemia.门腔分流术和肝移植治疗家族性高胆固醇血症。
Arteriosclerosis. 1989 Jan-Feb;9(1 Suppl):I158-63.
7
Glomerular structures and lipids in progressive renal disease.
Am J Med. 1989 Nov;87(5N):12N-20N.
8
Regulation of the mevalonate pathway.甲羟戊酸途径的调控
Nature. 1990 Feb 1;343(6257):425-30. doi: 10.1038/343425a0.
9
Portacaval shunt and hyperlipidemia.门腔分流术与高脂血症
Arch Surg. 1978 Jan;113(1):71-4. doi: 10.1001/archsurg.1978.01370130073012.
10
Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.一名纯合子家族性高胆固醇血症患者门腔分流术后胆固醇及低密度脂蛋白合成减少。
J Clin Invest. 1975 Dec;56(6):1420-30. doi: 10.1172/JCI108223.